Division of Endocrinology, Diabetes and Metabolism, University of California, San Diego, San Diego, CA, USA.
Department of Nursing Education, Development and Research, University of California, San Diego, San Diego, CA, USA.
J Diabetes Sci Technol. 2021 Mar;15(2):214-221. doi: 10.1177/1932296820966616. Epub 2020 Oct 29.
Computerized insulin infusion protocols have demonstrated higher staff satisfaction, better compliance with protocols, and increased time with glucose in range compared to paper protocols. At University of California San Diego Health (UCSDH), we implemented an insulin infusion computer calculator (IICC) and transitioned it from a web-based platform directly into the electronic medication administration record (eMAR) of our primary electronic health record (EHR).
This is a retrospective analysis of 6306 adult patients at UCSDH receiving intravenous (IV) insulin infusion from March 7, 2013 to May 30, 2019. We created three periods of the study-(1) the pre-eMAR integration period; (2) the eMAR integration period; and (3) the post-eMAR integration period-and looked at the percentage of readings within goal range (90-150 mg/dL for intensive care unit [ICU], 90-180 mg/dL for non-ICU) in patients with and without hyperglycemic emergencies. As our safety endpoints, we elected to look at incidence of blood glucose (BG) readings <70 mg/dL, <54 mg/dL, and <40 mg/dL.
Pre-eMAR 69.8% of readings were in the 90-150 mg/dL range compared to 70.2% post-eMAR ( = .03) and 82.7% of readings were in the 90-180 mg/dL range pre-eMAR versus 82.9% ( = .09) post-eMAR in patients without hyperglycemic emergencies. Rates of hypoglycemia with BG <70 mg/dL were 0.43%, <54 mg/dL were 0.07%, and <40 mg/dL were 0.01% of readings pre- and post-eMAR.
At UCSDH, our IICC has shown to be safe and effective in a wide variety of clinical situations and we were able to successfully transition it from a web-based platform directly into the eMAR of our primary EHR.
与纸质方案相比,计算机胰岛素输注方案显示出更高的医护人员满意度、更好的方案依从性以及更多的血糖达标时间。在加利福尼亚大学圣地亚哥分校健康中心(UCSDH),我们实施了胰岛素输注计算机计算器(IICC),并将其从基于网络的平台直接过渡到我们主要电子健康记录(EHR)的电子医嘱记录(eMAR)中。
这是对 UCSDH 2013 年 3 月 7 日至 2019 年 5 月 30 日期间接受静脉(IV)胰岛素输注的 6306 例成年患者的回顾性分析。我们创建了研究的三个时期-(1) 预 eMAR 整合期;(2) eMAR 整合期;和 (3) eMAR 整合后期,并观察了有和无高血糖急症患者的目标范围内(重症监护病房[ICU]为 90-150mg/dL,非 ICU 为 90-180mg/dL)读数的百分比。作为我们的安全终点,我们选择观察血糖(BG)读数<70mg/dL、<54mg/dL 和 <40mg/dL 的发生率。
预 eMAR 有 69.8%的读数处于 90-150mg/dL 范围内,而 eMAR 后有 70.2%(=0.03),无高血糖急症患者的预 eMAR 读数中有 82.7%处于 90-180mg/dL 范围内,而 eMAR 后有 82.9%(=0.09)。BG<70mg/dL 的低血糖发生率为 0.43%,<54mg/dL 的发生率为 0.07%,<40mg/dL 的发生率为 0.01%,在 eMAR 前后。
在 UCSDH,我们的 IICC 在各种临床情况下都表现出安全有效,我们能够成功地将其从基于网络的平台直接过渡到我们主要 EHR 的 eMAR。